# Emory Vaccine and Treatment Evaluation Unit - DMID 20-0034

> **NIH NIH UM1** · EMORY UNIVERSITY · 2021 · $669,970

## Abstract

Summary/Abstract
The Emory VTEU has proven essential in the fight against the pandemic. This supplement will
allow for further investigations into second generation vaccines trials (20-0034).
1

## Key facts

- **NIH application ID:** 10358952
- **Project number:** 3UM1AI148576-02S1
- **Recipient organization:** EMORY UNIVERSITY
- **Principal Investigator:** EVAN J ANDERSON
- **Activity code:** UM1 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $669,970
- **Award type:** 3
- **Project period:** 2021-03-17 → 2026-11-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10358952

## Citation

> US National Institutes of Health, RePORTER application 10358952, Emory Vaccine and Treatment Evaluation Unit - DMID 20-0034 (3UM1AI148576-02S1). Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/grant/nih/10358952. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*